FOLH1 and prostate carcinoma: In our previous study, we established that PSMA-OSP12 NPs possess excellent tumor-targeting capability and high-performance NIR-II fluorescence emission, enabling accurate molecular imaging and diagnostic applications in prostate cancer (25).